Literature DB >> 34988912

From data to QSP models: a pipeline for using Boolean networks for hypothesis inference and dynamic model building.

M Putnins1, O Campagne2, D E Mager2, I P Androulakis3,4.   

Abstract

Quantitative Systems Pharmacology (QSP) models capture the physiological underpinnings driving the response to a drug and express those in a semi-mechanistic way, often involving ordinary differential equations (ODEs). The process of developing a QSP model generally starts with the definition of a set of reasonable hypotheses that would support a mechanistic interpretation of the expected response which are used to form a network of interacting elements. This is a hypothesis-driven and knowledge-driven approach, relying on prior information about the structure of the network. However, with recent advances in our ability to generate large datasets rapidly, often in a hypothesis-neutral manner, the opportunity emerges to explore data-driven approaches to establish the network topologies and models in a robust, repeatable manner. In this paper, we explore the possibility of developing complex network representations of physiological responses to pharmaceuticals using a logic-based analysis of available data and then convert the logic relations to dynamic ODE-based models. We discuss an integrated pipeline for converting data to QSP models. This pipeline includes using k-means clustering to binarize continuous data, inferring likely network relationships using a Best-Fit Extension method to create a Boolean network, and finally converting the Boolean network to a continuous ODE model. We utilized an existing QSP model for the dual-affinity re-targeting antibody flotetuzumab to demonstrate the robustness of the process. Key output variables from the QSP model were used to generate a continuous data set for use in the pipeline. This dataset was used to reconstruct a possible model. This reconstruction had no false-positive relationships, and the output of each of the species was similar to that of the original QSP model. This demonstrates the ability to accurately infer relationships in a hypothesis-neutral manner without prior knowledge of a system using this pipeline.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Boolean network; Dynamic models; Machine learning; QSP

Mesh:

Substances:

Year:  2022        PMID: 34988912     DOI: 10.1007/s10928-021-09797-2

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.410


  41 in total

Review 1.  Diseases as network perturbations.

Authors:  Antonio del Sol; Rudi Balling; Lee Hood; David Galas
Journal:  Curr Opin Biotechnol       Date:  2010-08-13       Impact factor: 9.740

Review 2.  Drug target identification through systems biology.

Authors:  Jurgen R Haanstra; Barbara M Bakker
Journal:  Drug Discov Today Technol       Date:  2015-07-17

Review 3.  Network analyses in systems pharmacology.

Authors:  Seth I Berger; Ravi Iyengar
Journal:  Bioinformatics       Date:  2009-07-30       Impact factor: 6.937

Review 4.  Networks for systems biology: conceptual connection of data and function.

Authors:  F Emmert-Streib; M Dehmer
Journal:  IET Syst Biol       Date:  2011-05       Impact factor: 1.615

Review 5.  Studying protein-protein interaction networks: a systems view on diseases.

Authors:  Ferenc Jordán; Thanh-Phuong Nguyen; Wei-Chung Liu
Journal:  Brief Funct Genomics       Date:  2012-08-20       Impact factor: 4.241

Review 6.  Systems pharmacology - Towards the modeling of network interactions.

Authors:  Meindert Danhof
Journal:  Eur J Pharm Sci       Date:  2016-04-27       Impact factor: 4.384

Review 7.  Role of systems pharmacology in understanding drug adverse events.

Authors:  Seth I Berger; Ravi Iyengar
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-08-27

8.  Quantitative Systems Pharmacology: A Framework for Context.

Authors:  Ioannis P Androulakis
Journal:  Curr Pharmacol Rep       Date:  2016-04-08

9.  Systems pharmacology and genome medicine: a future perspective.

Authors:  Aislyn D Wist; Seth I Berger; Ravi Iyengar
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

10.  FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?

Authors:  M C Peterson; M M Riggs
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-03-12
View more
  2 in total

1.  Towards a comprehensive assessment of QSP models: what would it take?

Authors:  Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-08-13       Impact factor: 2.410

2.  Editor's note on the themed issue: integration of machine learning and quantitative systems pharmacology.

Authors:  Peter L Bonate
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-02       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.